Published in Gastroenterology on April 01, 1996
Functional gastroduodenal disorders. Gut (1999) 3.74
Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology (2010) 2.30
Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia. J Gastroenterol (2013) 1.97
Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol (2011) 1.88
The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology (2008) 1.77
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria. Gut (2014) 1.60
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol (2008) 1.49
Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut (2003) 1.44
Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut (2005) 1.32
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci (1998) 1.31
Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol (2011) 1.26
Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci (2001) 1.25
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22
Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Dig Dis Sci (2009) 1.08
Recent insights into digestive motility in functional dyspepsia. J Gastroenterol (2006) 1.05
The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia. BMC Med Genet (2010) 1.04
Homozygous 825T allele of the GNB3 protein influences the susceptibility of Japanese to dyspepsia. Dig Dis Sci (2007) 1.04
G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome. J Neurogastroenterol Motil (2012) 1.04
Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 1.03
Functional dyspepsia: are psychosocial factors of relevance? World J Gastroenterol (2006) 1.03
What comes after macrolides and other motilin stimulants? Gut (2001) 1.02
Novel mechanisms in functional dyspepsia. World J Gastroenterol (2006) 1.02
Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol (2006) 1.00
Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil (2010) 0.99
Principles of applied neurogastroenterology: physiology/motility-sensation. Gut (1999) 0.99
Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut (2005) 0.98
Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg". J Neurogastroenterol Motil (2012) 0.98
Food intolerance, diet composition, and eating patterns in functional dyspepsia patients. Dig Dis Sci (2009) 0.96
Pathophysiology of functional dyspepsia. Gut (2002) 0.94
Serotonergic modulating drugs for functional gastrointestinal diseases. Br J Clin Pharmacol (2002) 0.93
Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci (2003) 0.93
Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 0.91
Significance of autonomic nervous system activity in functional dyspepsia. Dig Dis Sci (2000) 0.90
Psychological and sex features of delayed gut transit in functional gastrointestinal disorders. Gut (2000) 0.90
Gastric emptying in migraine: a comparison with functional dyspepsia. J Neurogastroenterol Motil (2012) 0.90
Evaluation and management of dyspepsia. Therap Adv Gastroenterol (2010) 0.89
Treatment options for patients with severe gastroparesis. Gut (2007) 0.89
Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut (2005) 0.89
Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastroenterol Motil (2010) 0.88
Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability. Dig Dis Sci (2002) 0.88
Lack of relationship between chronic upper abdominal symptoms and gastric function in functional dyspepsia. Dig Dis Sci (2007) 0.88
Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography. J Gastroenterol (2008) 0.87
Serotonin transporter gene polymorphism may be associated with functional dyspepsia in a Japanese population. BMC Med Genet (2011) 0.87
Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction. Surg Endosc (2008) 0.87
Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci (2000) 0.87
Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci (2002) 0.87
Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther (2014) 0.86
Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria. Am J Gastroenterol (2016) 0.86
Association of endoscopic appearances with dyspeptic symptoms. J Gastroenterol (2008) 0.86
Evaluation and treatment of dyspepsia. Postgrad Med J (2003) 0.85
Early satiety is the only patient-reported symptom associated with delayed gastric emptying, as assessed by breath-test. J Neurogastroenterol Motil (2011) 0.85
Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome. Front Pharmacol (2014) 0.85
Idiopathic gastroparesis. Gastroenterol Clin North Am (2014) 0.84
Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol (2013) 0.84
Edrophonium provocative testing during electrogastrography (EGG): effects on dyspeptic symptoms and the EGG. Dig Dis Sci (1998) 0.84
Subtypes of functional dyspepsia. World J Gastroenterol (2006) 0.83
Relationship between gastrointestinal and extra-gastrointestinal symptoms and delayed gastric emptying in functional dyspeptic patients. World J Gastroenterol (2005) 0.83
Effects of occupational stress on the gastrointestinal tract. World J Gastrointest Pathophysiol (2013) 0.83
Role of cholecystokinin and central serotonergic receptors in functional dyspepsia. World J Gastroenterol (2006) 0.83
Gastric emptying of liquid and solid meals at various temperatures: effect of meal temperature for gastric emptying. J Gastroenterol (2009) 0.83
Drink tests in functional dyspepsia. Gastroenterology (2002) 0.83
Prevalence of Gastric Motility Disorders in Patients with Functional Dyspepsia. J Neurogastroenterol Motil (2017) 0.82
Gastric hypochlorhydria is associated with an exacerbation of dyspeptic symptoms in female patients. J Gastroenterol (2012) 0.82
Gastric emptying in patients with functional dyspepsia and patients with migraine. J Neurogastroenterol Motil (2013) 0.82
Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysis. ScientificWorldJournal (2014) 0.82
Meeting the need for women's health training in gastroenterology: creation of a women's digestive disorders program at Brown University. J Womens Health (Larchmt) (2010) 0.81
Pattern of gastric emptying in functional dyspepsia. An ultrasonographic study. Dig Dis Sci (2004) 0.81
Plasma levels of acylated ghrelin in patients with functional dyspepsia. World J Gastroenterol (2012) 0.81
Relationship of gastrointestinal symptoms and psychosocial distress to gastric retention in children. J Pediatr (2014) 0.81
Role of indigenous lactobacilli in gastrin-mediated acid production in the mouse stomach. Appl Environ Microbiol (2011) 0.80
Variable abnormal physiological motility in the proximal upper gastrointestinal tract in gastroparesis. Neurogastroenterol Motil (2012) 0.80
Chronic gastritis is not associated with gastric dysrhythmia or delayed solid emptying in children with dyspepsia. Dig Dis Sci (2005) 0.80
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol (2017) 0.79
Relationship between antral distension and postprandial symptoms in functional dyspepsia. World J Gastroenterol (2006) 0.79
Gastroparesis: current concepts and management. Gut Liver (2009) 0.79
Metoclopramide in the treatment of diabetic gastroparesis. Expert Rev Endocrinol Metab (2010) 0.79
Effect of intranasal sumatriptan on gastric tone and sensitivity to distension. Dig Dis Sci (2001) 0.79
Gastric sensitivity and reflexes: basic mechanisms underlying clinical problems. J Gastroenterol (2013) 0.79
Correlation of gastric liquid emptying with various thresholds of sensation in healthy controls and patients with functional dyspepsia. Dig Dis Sci (2004) 0.79
Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes. Int J Health Sci (Qassim) (2016) 0.78
How should Helicobacter pylori negative patients be managed? Gut (1999) 0.78
Leu72Met408 Polymorphism of the Ghrelin Gene Is Associated With Early Phase of Gastric Emptying in the Patients With Functional Dyspepsia in Japan. J Neurogastroenterol Motil (2015) 0.78
High degree of duodenal inflammation in Nigerians with functional dyspepsia. Clin Exp Gastroenterol (2013) 0.78
Electrical bioimpedance and other techniques for gastric emptying and motility evaluation. World J Gastrointest Pathophysiol (2012) 0.78
A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgrad Med J (2002) 0.78
Treatment of Functional Dyspepsia. Curr Treat Options Gastroenterol (2003) 0.77
Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication. J Gastroenterol (2015) 0.77
From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries. Dig Dis Sci (2014) 0.77
Why do irritable bowel syndrome women often have nausea symptom? J Neurogastroenterol Motil (2012) 0.77
Real-time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy. J Gastroenterol (2008) 0.77
Nitric oxide synthase gene polymorphisms in functional dyspepsia. Dig Dis Sci (2013) 0.77
Functional Dyspepsia: Impaired Fundic Accommodation. Curr Treat Options Gastroenterol (2000) 0.77
A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction. Evid Based Complement Alternat Med (2015) 0.77
Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial. PLoS One (2015) 0.77
Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function. Br J Clin Pharmacol (2004) 0.76
Prevalence and determinants of delayed gastric emptying in hospitalised Type 2 diabetic patients. World J Gastroenterol (2008) 0.76
Randomized trial assessing gastric emptying in patients with chronic hepatitis C during interferon-alpha or -beta therapy and effect of cisapride. Dig Dis Sci (2002) 0.75
The Overlap Between GERD and Functional Bowel Disorders - When East Meets Rome. J Neurogastroenterol Motil (2010) 0.75
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol (2001) 4.46
Diabetes and the risk of pancreatic cancer. N Engl J Med (1994) 3.78
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med (2000) 2.40
Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med (1997) 2.33
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut (2004) 2.04
Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis (2006) 1.85
Thiamine-responsive anemia in DIDMOAD syndrome. J Pediatr (1989) 1.85
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther (2009) 1.83
Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab (2000) 1.67
The general practitioner's approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis (2005) 1.62
Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol (1998) 1.61
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. Dig Liver Dis (2005) 1.52
Prognostic value of captopril renal scintigraphy in renovascular hypertension. J Nucl Med (1992) 1.45
New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.45
The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats. Neurogastroenterol Motil (2008) 1.44
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut (2004) 1.44
Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose. Emerg Med J (2003) 1.44
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol (2005) 1.41
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol (1994) 1.38
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil (2007) 1.35
New insights into human enteric neuropathies. Neurogastroenterol Motil (2004) 1.31
Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther (2001) 1.24
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A (1999) 1.22
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci (1995) 1.17
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? Gastroenterology (1999) 1.16
Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest (2007) 1.15
68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors. Eur J Nucl Med Mol Imaging (2007) 1.15
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology (1993) 1.13
Gastric secretion and emptying of liquids in reflex esophagitis. Dig Dis Sci (1981) 1.11
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer (2004) 1.10
Function of the internal anal sphincter and rectal sensitivity in idiopathic constipation. Digestion (1982) 1.10
Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol (1999) 1.09
Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study. Aliment Pharmacol Ther (1998) 1.08
Diagnostic value of plasma chromogranin A in neuroendocrine tumours. Eur J Gastroenterol Hepatol (2001) 1.07
Blood alcohol concentration and management of road trauma patients in the emergency department. J Trauma (2001) 1.07
Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol (1999) 1.07
Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Dig Liver Dis (2007) 1.05
Quality of life in patients with chronic pancreatitis. Dig Liver Dis (2004) 1.04
High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci (1997) 1.03
Childhood obesity: results of a multicenter study of obesity treatment in Italy. J Pediatr Endocrinol Metab (1999) 1.03
Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol (2002) 1.02
Prospective validation of a proposal for diagnosis and management of patients attending the emergency department for mild head injury. J Neurol Neurosurg Psychiatry (2004) 1.02
Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations. Br J Pharmacol (2000) 1.02
Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol (2000) 1.01
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med (1998) 0.99
First polar body morphology before ICSI is not related to embryo quality or pregnancy rate. Hum Reprod (2004) 0.98
Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med (2000) 0.97
Anti-CagA reactivity in Helicobacter pylori-negative subjects: a comparison of three different methods. Dig Dis Sci (1999) 0.97
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol (2000) 0.97
Severity of acute pancreatitis: relationship with etiology, sex and age. Hepatogastroenterology (1999) 0.97
Simultaneous serum assays of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis. Clin Chem (1999) 0.96
The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) (1999) 0.96
Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol (2001) 0.96
Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol (1988) 0.96
Evaluation of hypertensive patients by means of captopril enhanced renal scintigraphy with technetium-99m DTPA. J Nucl Med (1989) 0.95
Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR. Aliment Pharmacol Ther (2000) 0.94
Gastric emptying of solids in morbid obesity. Int J Obes Relat Metab Disord (1996) 0.94
Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man. Int J Clin Pharmacol Ther Toxicol (1984) 0.91
Management of Helicobacter pylori-related gastrointestinal diseases by general practitioners in Italy. Aliment Pharmacol Ther (1999) 0.91